Patient-Centered and Rare Diseases Discussion Group
Author(s)
Moderator: Andrew Lloyd, DPhil, Acaster Lloyd Consulting Ltd, London, UK
Open to all attendees; seating is limited.
This Discussion Group will focus on and feature speakers from the session: 103: How Can the Voice of the Patient be Better Heard in HTA Decision Making in Rare Diseases? (Monday, 7 November, 10:15 - 11:15).
Conference/Value in Health Info
2022-11, ISPOR Europe 2022, Vienna, Austria
Code
114
Topic
Patient-Centered Research